Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants
Citation: Watson J., & McGuire W. Nasal versus oral route for placing feeding tubes in preterm or low birth weight infants. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD003952.
The data recovered in this review do not provide sufficient evidence to inform policy or practice regarding whether the nasal versus the oral route of enteral feeding tube placement is preferable for preterm or low birth weight infants.
Enteral feeding tubes for preterm or low birth weight infants may be placed via either the nose or mouth. Nasal placement may compromise respiration, but orally placed tubes may be more prone to displacement, local irritation, and vagal stimulation. This review aims to determine the effect of nasal versus oral placement of enteral feeding tubes on feed tolerance, growth and development, and the incidence of adverse events in preterm or low birth weight infants.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.